Dr Reddy’s Lab Q4 results: Net profit up 36.3% on year; announces dividend
Dr Reddy’s Laboratories: The company’s net profit and revenue both grew in the quarter ending March FY24. (Image: Freepik)
The pharma-major Dr Reddy’s Laboratories recorded a net profit of Rs 1,307 crore in the last quarter of the financial year 2023-24, compared to Rs 959.2 crore it reported in Q4 of FY23, an increase of 36.3% on year.
Its revenue grew to Rs 7,083 crore in Q4 of FY24, a growth of 12.5% on year, compared to Rs 6,296.8 crore it posted in the same period a year ago.
Dividend in Q4
The company’s board of directors has declared a dividend of Rs 40 per equity share. “Recommended a final dividend of Rs 40/- (800%) per equity share of Rs. 5/- each for the financial year 2023-24. “The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the ensuing 40th annual general meeting (AGM) of the company,” said Dr Reddy’s Laboratories.